Molecular Data Inc
NASDAQ:MKD
Molecular Data Inc
Selling, General & Administrative
Molecular Data Inc
Selling, General & Administrative Peer Comparison
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
M
|
Molecular Data Inc
NASDAQ:MKD
|
Selling, General & Administrative
-¥286m
|
CAGR 3-Years
-34%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Selling, General & Administrative
-¥152B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-34%
|
|
Pinduoduo Inc
NASDAQ:PDD
|
Selling, General & Administrative
-¥86.3B
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
N/A
|
|
JD Health International Inc
HKEX:6618
|
Selling, General & Administrative
-¥8.9B
|
CAGR 3-Years
-63%
|
CAGR 5-Years
-55%
|
CAGR 10-Years
N/A
|
|
Meituan
HKEX:3690
|
Selling, General & Administrative
-¥68B
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
JD.Com Inc
HKEX:9618
|
Selling, General & Administrative
-¥113B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-33%
|
See Also
What is Molecular Data Inc's Selling, General & Administrative?
Selling, General & Administrative
-286m
CNY
Based on the financial report for Dec 31, 2020, Molecular Data Inc's Selling, General & Administrative amounts to -286m CNY.
What is Molecular Data Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 3Y
-34%
Over the last year, the Selling, General & Administrative growth was -16%. The average annual Selling, General & Administrative growth rates for Molecular Data Inc have been -34% over the past three years .